Status:
COMPLETED
Ezra Faster Scan Study
Lead Sponsor:
Ezra AI, Inc.
Conditions:
Medical Oncology
Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The Ezra Faster Scan study uses non-invasive magnetic resonance imaging (MRI) technology that can "visually" detect early and late-stage cancer, and other pathologies. MRIs use a magnetic field and ra...
Eligibility Criteria
Inclusion
- Ability to provide legal informed consent and 18 years of age or older
- Resident of the contiguous United States and located within proximity of a designated research MRI facility
- Ability to travel to designated research MRI facilities
Exclusion
- Unable to receive an MRI due to existing implanted medical devices that may be disrupted by magnetic field or metal components/fragments that may migrate due to magnetic fields (pacemaker or defibrillator, stimulators, or stimulator wires (pacing leads), non-removeable metal dentures/braces/wires, surgical clips, (drug) pumps. Note metallic dental crowns or fillings are permitted.
- Those with orbital (eye socket) trauma caused by a metallic object
- Those with metallic fragments within the eye (foundry workers)
- Those with implanted cardiac pacemakers, implantable cardioverter defibrillators (ICDs), or diaphragmatic pacemakers, cardiac resynchronization therapy devices, implantable cardiovascular monitors, implantable loop recorders, neurostimulators
- Those with intra-cranial vascular clips (aneurysm), or prosthetic heart valve
- Those with shrapnel form a prior accident
- Those with a LINX Reflux Management System to control gastro esophageal reflux disease (GERD)
- Those with non-removable insulin pumps or other drug pumps
- Those with cochlear implants
- Those with breast (inflatable breast tissue implants) or other tissue expanders (cosmetic or other implant)
- Those with tubal ligation clips or non-removable intrauterine device (IUD)
- Those with Sensimed Triggerfish ocular monitoring systems (glaucoma)
- Those receiving ambulatory care
- Employee of Ezra Health of California, P.C., Ezra AI Incorporated or Ezra AI Canada Incorporated
- Mental health disability, cognitive disability, neurological or other existing condition that may impact ability to provide informed consent
- Those that recently experienced a stroke that may impair judgement
- Those that have some difficulty or higher, remembering, concentrating, communicating, or being understood (sponsor reviewed)
- Individuals who otherwise may require a legally authorized individual (LAR) to provide consent on their behalf
- Those who do not have access to the internet through a mobile device or computer
- Those who are pregnant at the time of informed consent or prior to a scheduled MRI appointment
- Those who are incarcerated or on probation
- Those who may not have reading proficiency of study supported document languages (questionnaires, consent forms, or third-party oral translation services)
- Those who cannot read due to visual impairment and cannot provide an impartial witness to support informed consent or study survey questionnaires
- Those with a hearing impairment and cannot provide an impartial witness to support informed consent
Key Trial Info
Start Date :
June 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 24 2025
Estimated Enrollment :
694 Patients enrolled
Trial Details
Trial ID
NCT05385718
Start Date
June 1 2022
End Date
February 24 2025
Last Update
March 3 2025
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Various Locations
Beverly Hills, California, United States, 90211
2
Various Locations
Chino Hills, California, United States, 91709
3
Various Locations
Irvine, California, United States, 92604
4
Various Locations
Los Gatos, California, United States, 95032